nevirapine has been researched along with Immune Reconstitution Disease in 3 studies
Nevirapine: A potent, non-nucleoside reverse transcriptase inhibitor used in combination with nucleoside analogues for treatment of HIV INFECTIONS and AIDS.
nevirapine : A dipyridodiazepine that is 5,11-dihydro-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepine which is substituted by methyl, oxo, and cyclopropyl groups at positions 4, 6, and 11, respectively. A non-nucleoside reverse transcriptase inhibitor with activity against HIV-1, it is used in combination with other antiretrovirals for the treatment of HIV infection.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kyaw, NL | 1 |
| Thanachartwet, V | 1 |
| Kiertiburanakul, S | 1 |
| Desakorn, V | 1 |
| Chamnanchanunt, S | 1 |
| Chierakul, W | 1 |
| Manosuthi, W | 1 |
| Pitisuttithum, P | 1 |
| Sungkanuparph, S | 1 |
| Manga, NM | 1 |
| Poda, A | 1 |
| Bazolo, N | 1 |
| Sané, O | 1 |
| Batista, G | 1 |
| Guèye, NF | 1 |
| Sow, PS | 1 |
| Badiane, CI | 1 |
| Asmuth, DM | 1 |
| Ma, ZM | 1 |
| Mann, S | 1 |
| Knight, TH | 1 |
| Yotter, T | 1 |
| Albanese, A | 1 |
| Melcher, GP | 1 |
| Troia-Cancio, P | 1 |
| Hayes, T | 1 |
| Miller, CJ | 1 |
| Pollard, RB | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Pilot Project of Virologic, Pharmacologic and Immunologic Correlates of Gastrointestinal-Associated Lymphoid Tissue Immune Reconstitution Following Raltegravir Therapy[NCT00661960] | 25 participants (Actual) | Interventional | 2008-03-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Duodenal tissue immune cell subsets were measured by flow cytometry. (NCT00661960)
Timeframe: nine months
| Intervention | % CD3/CD4 T-cells in GALT tissue (Median) |
|---|---|
| Negative Volunteers | 55.3 |
| HIV-postive Randomized to Raltegravir | 11.7 |
| HIV-postive Randomized to NNRTI | 9.9 |
1 trial available for nevirapine and Immune Reconstitution Disease
| Article | Year |
|---|---|
Gastrointestinal-associated lymphoid tissue immune reconstitution in a randomized clinical trial of raltegravir versus non-nucleoside reverse transcriptase inhibitor-based regimens.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; CD4 Lymphocyte Count; CD4-Positive T-Lymphocyte | 2012 |
2 other studies available for nevirapine and Immune Reconstitution Disease
| Article | Year |
|---|---|
Baseline CD4 cell counts and outcomes among adult treatment naive HIV patients after taking fixed dose combination GPO-VIR-S and GPO-VIR-Z in Thailand.
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Female; Hematologic Tests; HIV Infections; Humans; Imm | 2013 |
[Immune reconstitution inflammatory syndrome and HIV leprosy co-infection].
Topics: Adrenal Cortex Hormones; Adult; Anti-HIV Agents; Dapsone; Diagnostic Errors; Female; HIV Infections; | 2011 |